Praj Industries, one of India’s leading biotech companies, has taken a giant leap towards sustainability with the unveiling of the country’s first demonstration facility for biopolymers. Located at Jejuri near Pune, this pioneering facility showcases Praj’s indigenously developed integrated Polylactic Acid (PLA) technology, pushing India to the forefront of eco-friendly innovation.

The facility was inaugurated on October 13, 2024, by Dr. Jitendra Singh, India’s Union Minister of State for Science and Technology. Also present were Dr. Rajesh Gokhale, Secretary of the Department of Biotechnology (DBT), and Dr. Ashish Lele, Director of the National Chemical Laboratory. This launch underscores India’s drive to reduce plastic pollution and adopt biodegradable alternatives as part of its broader push towards a circular economy.

Praj’s Bold Vision for a Bioeconomy

Praj Industries, well-known for its leadership in industrial biotechnology, aims to pioneer the transition from fossil-based products to renewable, bio-based solutions. The company’s newly developed PLA facility is set to produce 100 tons of lactic acid per annum, 60 tons of lactide, and 55 tons of PLA. Spread over three acres, the facility integrates fermentation, chemical synthesis, and purification, highlighting Praj’s expertise in industrial-scale biopolymer production.

“This demonstrates India’s strong lead in technological innovation,” Dr. Jitendra Singh noted during the inauguration. He emphasized how this facility contributes to India’s initiatives like “Atmanirbhar Bharat” and “Make-in-India,” making the country self-reliant in biomanufacturing capabilities.

From Biofuels to Bioplastics: A Strategic Diversification

Praj Industries has successfully leveraged its extensive experience in biofuels to expand into renewable chemicals and bioplastics. The company’s Bio-Prism® portfolio aims to deliver a broad spectrum of solutions under renewable chemicals and materials (RCM). PLA is the first biopolymer in this portfolio to achieve large-scale demonstration, signifying a crucial step in developing India’s bioeconomy.

The company’s Founder Chairman, Dr. Pramod Chaudhari, explained, “The decision to diversify into renewable chemicals and bioplastics was made during the challenging period of the COVID-19 pandemic. Our focus on bioplastics is aimed at establishing India as a global bio-manufacturing hub while also tackling the plastic crisis.”

The Threat of Conventional Plastics and the Need for Change

According to a recent report by the United Nations titled “Chemicals in Plastics, 2023,” conventional plastics pose significant health risks. These risks include the release of over 3,200 harmful plastic additives, which can cause cancer, respiratory disorders, hormonal disruptions, and infertility. Additionally, single-use plastics (SUPs) have had a disastrous effect on aquatic ecosystems, suffocating marine life and adding millions of tons of waste to oceans.

With this new facility, Praj aims to replace harmful plastics with bio-based, biodegradable PLA. These bioplastics are made from natural monomers and contain safer additives, making them ideal for a range of applications, including food packaging, personal care, agriculture, and pharmaceuticals.

Collaboration for a Sustainable Future

Dr. Rajesh Gokhale expressed his appreciation for Praj’s achievements and noted how well these align with India’s recently launched Bio-E3 Policy (Biotechnology for Economy, Environment, and Employment) and the Bio-RIDE scheme (Biotechnology Research Innovation and Entrepreneurship Development). He stated that “Praj’s efforts will be instrumental in making India a global biomanufacturing hub.”

Dr. Ashish Lele, Director of the National Chemical Laboratory, emphasized the scale of the plastic crisis in India, noting that “India produces 25 million tons of plastic annually, of which only 3.4 million tons are collected for recycling. It is imperative to transition towards biodegradable and compostable bioplastics to address this alarming issue.” He also pointed out the importance of collaboration between industry, academia, and government to ensure these solutions are both scalable and impactful.

The Role of Praj Matrix R&D

Praj Matrix, the R&D arm of Praj Industries, has been the backbone of the company’s advancements in bioplastics. This state-of-the-art research facility has facilitated breakthroughs in integrated PLA technology, enabling the efficient production of biopolymers that are both functional and scalable. The demonstration facility at Jejuri is a testament to the company’s commitment to a sustainable future.

Market Sentiment and Stock Analysis

Praj Industries’ shares have shown positive movement following the announcement of the biopolymer facility, reflecting investor confidence in the company’s future. As of October 16, 2024, Praj Industries Limited’s stock is trading at INR 802.95 on NSE and INR 798.75 on BSE. Analysts believe that the company’s diversification into renewable materials and the increased focus on the global bioeconomy could propel Praj into a more robust market position. Investor sentiment remains optimistic, with experts highlighting Praj’s potential to capture a significant share of the growing bioplastics market.

The success of Praj’s PLA facility could pave the way for further innovations, allowing India to assert itself as a leader in sustainable, bio-based technologies.

  Bio-E3 Policy, Bio-Prism, Bio-RIDE Scheme, Dr. Ashish Lele, Dr. Jitendra Singh, Dr. Rajesh Gokhale, Jejuri, National Chemical Laboratory, Polylactic Acid Technology, Praj Industries, Pune